Le Zhu

1.1k total citations · 2 hit papers
12 papers, 767 citations indexed

About

Le Zhu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Le Zhu has authored 12 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Le Zhu's work include Nanoplatforms for cancer theranostics (3 papers), Ferroptosis and cancer prognosis (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Le Zhu is often cited by papers focused on Nanoplatforms for cancer theranostics (3 papers), Ferroptosis and cancer prognosis (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Le Zhu collaborates with scholars based in China, Thailand and United States. Le Zhu's co-authors include Qiongzhu Dong, Lun–Xiu Qin, Yan Zheng, Beiyuan Hu, Tiantian Zou, Yan Fu, Xiaotian Shen, Wei Qin, Haoting Sun and Lu Lu and has published in prestigious journals such as Advanced Functional Materials, Cancer Research and Signal Transduction and Targeted Therapy.

In The Last Decade

Le Zhu

11 papers receiving 763 citations

Hit Papers

Isolation and characterization of exosomes for cancer res... 2020 2026 2022 2024 2020 2021 100 200 300

Peers

Le Zhu
Cecilia Monge United States
Tao Ma China
Le Zhu
Citations per year, relative to Le Zhu Le Zhu (= 1×) peers Ling‐Min Kong

Countries citing papers authored by Le Zhu

Since Specialization
Citations

This map shows the geographic impact of Le Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Zhu more than expected).

Fields of papers citing papers by Le Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Zhu. The network helps show where Le Zhu may publish in the future.

Co-authorship network of co-authors of Le Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Le Zhu. A scholar is included among the top collaborators of Le Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le Zhu. Le Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gao, Yonghui, Le Zhu, Lumin Zhang, et al.. (2025). Rational Design of Single‐Atom Nanozymes for Combination Cancer Immunotherapy. Advanced Functional Materials. 35(10). 10 indexed citations
2.
Xu, Fei, et al.. (2025). Fibroblast Activation Protein Promotes Pulmonary Artery Hypertension via Activation of the PTEN/PI3K/Akt Pathway. Journal of Cardiovascular Pharmacology. 86(4). 391–407.
3.
Shen, Xiaotian, Sun‐Zhe Xie, Xin Zheng, et al.. (2024). Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma. Experimental Hematology and Oncology. 13(1). 20–20. 14 indexed citations
4.
Fu, Yan, Hao Wang, Shun Wang, et al.. (2024). Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis. Signal Transduction and Targeted Therapy. 9(1). 63–63. 21 indexed citations
5.
Zhu, Le, Ming Ma, Lumin Zhang, et al.. (2023). System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy. Pharmaceutics. 15(3). 810–810. 4 indexed citations
6.
Zhu, Le, Lei Xiong, Wentao Xu, et al.. (2023). A combination of all-trans retinoic acid derivative and COX-2 inhibitor has anticancer effects in human pharyngeal carcinoma cells. Heliyon. 9(11). e21664–e21664. 1 indexed citations
7.
Hu, Beiyuan, Tiantian Zou, Wei Qin, et al.. (2022). Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma. Cancer Research. 82(20). 3845–3857. 104 indexed citations
8.
Wang, Shun, Yan Zheng, Yang Feng, et al.. (2021). The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduction and Targeted Therapy. 6(1). 249–249. 220 indexed citations breakdown →
9.
Zhu, Le, Haoting Sun, Shun Wang, et al.. (2020). Isolation and characterization of exosomes for cancer research. Journal of Hematology & Oncology. 13(1). 152–152. 376 indexed citations breakdown →
10.
Cao, Feng, Le Zhu, Jing Zhang, et al.. (2020). Myosin light chain kinase is a potential target for hypopharyngeal cancer treatment. Biomedicine & Pharmacotherapy. 131. 110665–110665. 7 indexed citations
11.
Xue, Min, Chenhao Zhou, Yan Zheng, et al.. (2020). The association between KLF4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection. Aging. 12(15). 15566–15580. 9 indexed citations
12.
Zhu, Le. (2014). Clinicopathological Significance of the Expression of Notch1 in Human Pancreatic Cancer. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026